Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies.

Autor: Scharffenberger SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA., Wan YH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Homad LJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Kher G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Haynes AM; Department of Global Health, University of Washington, Seattle, WA 98195, USA., Poudel B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Sinha IR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Aldridge N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Pai A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Bibby M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Chhan CB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Global Health, University of Washington, Seattle, WA 98195, USA., Davis AR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Moodie Z; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., Palacio MB; Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA 19104, USA., Escolano A; Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA 19104, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Medicine, University of Washington, Seattle, WA 98195, USA., Boonyaratanakornkit J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Global Health, University of Washington, Seattle, WA 98195, USA; Department of Medicine, University of Washington, Seattle, WA 98195, USA., Pancera M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA., McGuire AT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA; Department of Global Health, University of Washington, Seattle, WA 98195, USA. Electronic address: amcguire@fredhutch.org.

Publikováno v: Cell reports [Cell Rep] 2024 Oct 22; Vol. 43 (10), pp. 114811. Date of Electronic Publication: 2024 Oct 08.

Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.

Autor: Geboers B; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia.; Department of Urology, St. Vincent's Private Clinic, Sydney, New South Wales, Australia.; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam, The Netherlands., Scheltema MJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia.; Department of Urology, St. Antonius Hospital, Utrecht, The Netherlands., Jung J; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Bakker J; Department of Medical Oncology, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands., Timmer FEF; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam, The Netherlands., Cerutti X; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Katelaris A; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Doan P; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Gondoputro W; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Blazevski A; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Agrawal S; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Matthews J; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia.; Department of Urology, St. Vincent's Private Clinic, Sydney, New South Wales, Australia., Haynes AM; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia., Robertson T; Department of Anesthesiology, St. Vincent's Private Clinic, Sydney, New South Wales, Australia., Thompson JE; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia., Meijerink MR; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam, The Netherlands., Clark SJ; Garvan Institute of Medical Research and The Kinghorn Cancer Centre, Sydney, New South Wales, Australia., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC, Location Vrije Universiteit, Amsterdam, The Netherlands.; Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Amsterdam, The Netherlands., Stricker PD; St. Vincent's Prostate Cancer Research Centre, Sydney, New South Wales, Australia.; Department of Urology, St. Vincent's Private Clinic, Sydney, New South Wales, Australia.

Publikováno v: BJU international [BJU Int] 2024 Aug 05. Date of Electronic Publication: 2024 Aug 05.

Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy.

Autor: Geboers B; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Radiology and Nuclear Medicine, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Meijer D; Department of Urology, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Counter W; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Blazevski A; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Thompson J; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Urology, St. George Hospital, Sydney, NSW, Australia., Doan P; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Gondoputro W; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Katelaris A; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia., Haynes AM; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia., Delprado W; Douglas Hanly Moir Pathology, Sydney, NSW, Australia., O'Neill G; Department of Urology, St. Vincent's Hospital and Private Clinic, Sydney, NSW, Australia., Yuen C; Department of Urology, St. Vincent's Hospital and Private Clinic, Sydney, NSW, Australia., Vis AN; Department of Urology, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., van Leeuwen PJ; Department of Urology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Ho B; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Liu V; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Lee J; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Donswijk ML; Department of Radiology and Nuclear Medicine, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, The Netherlands., Oprea-Lager D; Department of Radiology and Nuclear Medicine, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Scheltema MJ; Garvan Institute of Medical Research & The Kinghorn Cancer Centre, Sydney, NSW, Australia.; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Urology, Amsterdam UMC (location VUmc), Amsterdam, The Netherlands., Emmett L; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, NSW, Australia., Stricker PD; St. Vincent's Prostate Cancer Research Centre, Sydney, NSW, Australia.; Department of Urology, St. Vincent's Hospital and Private Clinic, Sydney, NSW, Australia.

Publikováno v: BJU international [BJU Int] 2024 Apr; Vol. 133 Suppl 4, pp. 14-22. Date of Electronic Publication: 2023 Nov 08.